Core Points - The company Xi Di Wei (688173.SH) announced a share reduction plan by its Vice President and core technical personnel Fan Jun, who intends to sell up to 3,000,000 shares, representing no more than 0.73% of the total share capital, within three months after the announcement [1] - As of the announcement date, Fan Jun holds 13,049,225 shares, accounting for 3.18% of the total share capital, all of which are unrestricted shares obtained before the company's IPO [1] - The company has no controlling shareholder, with actual controllers being Dai Zuyu, Tao Hai, and Tang Ya [1] Company Background - Xi Di Wei was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 21, 2022, with an initial public offering of 40.01 million shares at a price of 33.57 yuan per share [2] - The stock reached a peak price of 51.88 yuan on its first trading day but is currently in a state of decline [3] - The total funds raised from the IPO amounted to 1.343 billion yuan, with a net amount of 1.221 billion yuan after deducting issuance costs, exceeding the original plan by 640 million yuan [3] Fund Utilization - The funds raised are intended for various projects, including the development and industrialization of high-performance power management chips for consumer electronics and communication devices, as well as new-generation automotive and industrial power management chips [3] - The total issuance costs for the IPO were 122 million yuan, with underwriting and sponsorship fees amounting to 102 million yuan [4]

Business Performance - Luxshare Technology plans to issue H-shares and list on the Hong Kong Stock Exchange [1] - China Shipbuilding Industry Corporation will suspend trading from August 13 until delisting [1] - Hikvision's chairman proposed a mid-term dividend of 4 yuan per 10 shares (including tax) for 2025 [1] - North Medical's subsidiary has essentially halted its main business since June [1] - Shenzhen Huangting Plaza will be judicially auctioned with a starting price of 3.053 billion yuan [1] - ST Suwu's controlling subsidiary has initiated arbitration against Regen Biotech for default, which has been accepted [1] - ST Yigou plans to pay 220 million yuan to reach a debt settlement agreement with Carrefour [1] - Shanghai Jianke's director is under disciplinary review and investigation [1] Mergers and Acquisitions - Xincheng Technology has terminated the acquisition of 96.96% equity in Tianyi Enhua [1] - Guangku Technology intends to purchase 100% equity in Suzhou Anjie Xun Optoelectronics, with resumption of trading on the 12th [1] - ST Biology plans to acquire 51% equity in Huize Pharmaceutical, expected to constitute a major asset restructuring [1] - Dongfang Guoxin aims to gain control of Shituo Cloud to deepen its layout in the intelligent computing power sector [1] - Jinding Investment intends to control Nanjing Shenyuan, entering a key segment of the robotics industry chain [1] - Huangshanghuang plans to acquire 51% equity in Lixing Food for 495 million yuan [1] Financial Performance - Xianggang Technology reported a net profit of 78.32 million yuan in the first half, a year-on-year increase of 432.14% [1] - Yonghe Co. reported a net profit of 271 million yuan in the first half, a year-on-year increase of 140.82% [1] - Fuda Co. reported a net profit of 146 million yuan in the first half, a year-on-year increase of 98.77% [1] - Desay SV reported a net profit of 1.223 billion yuan in the first half, a year-on-year increase of 45.82% [1] - Dier Laser reported a net profit of 327 million yuan in the first half, a year-on-year increase of 38.37% [1] - Rijiu Optoelectronics reported a net profit of 45.61 million yuan in the first half, a year-on-year increase of 37.87% [1] - Wolong Electric Drive reported a net profit of 537 million yuan in the first half, a year-on-year increase of 36.76% [1] - Satellite Chemical reported a net profit of 2.744 billion yuan in the first half, a year-on-year increase of 33.44% [1] Other Financial Results - High Stakes Mining reported a net profit of 69.2 million yuan in the first half, a year-on-year increase of 25.7% [2] - Yingliu Co. reported a net profit of 188 million yuan in the first half, a year-on-year increase of 23.91% [2] - Nanwei Medical reported a year-on-year net profit increase of 17.04% and plans to distribute a dividend of 5 yuan per 10 shares (including tax) [2] - Zhejiang Huaye reported a year-on-year net profit increase of 6.66% and plans to distribute a dividend of 4 yuan per 10 shares (including tax) [2] - New Strong Union reported a net profit of 400 million yuan in the first half, returning to profitability [2] - Aobi Zhongguang reported a net profit of 60.19 million yuan in the first half, returning to profitability [2] - Action Education reported a year-on-year net profit decrease of 3.51% and plans to distribute a dividend of 10 yuan per 10 shares (including tax) [2] - Wanhu Chemical reported a net profit of 6.123 billion yuan in the first half, a year-on-year decrease of 25.10% [2] - New World reported a net profit of 78.03 million yuan in the first half, a year-on-year decrease of 30.01% [2] - Huafeng Chemical reported a net profit of 983 million yuan in the first half, a year-on-year decrease of 35.23% [2] - Hefo China reported a consolidated revenue of 425 million yuan in the first seven months, a year-on-year decrease of 22.66%, with a narrowing decline [2] - Shengnong Development reported a sales revenue of 2.129 billion yuan in July, a year-on-year increase of 22.02% [2] - Xiamen Airport reported a passenger throughput of 2.6248 million in July, a year-on-year increase of 8.58% [2]

格隆汇8月11日丨希荻微(688173.SH)公布，公司于2025年8月11日收到范俊先生出具的《关于希荻微电 子集团股份有限公司股份减持计划的告知函》，范俊先生对公司前景持续看好，为满足自身资金需求， 拟通过集中竞价方式减持其持有的公司股份数量合计不超过3,000,000股，占公司目前总股本的比例合计 不超过0.73%，减持期间为本公告披露15个交易日后的3个月内。减持价格按照市场价格确定，若公司 在上述减持计划实施期间发生派发红利、送红股、转增股本、增发新股或配股等股本除权、除息事项 的，则上述减持计划将作相应调整。 ...

本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 证券代码：688173 证券简称：希荻微 公告编号：2025-064 希荻微电子集团股份有限公司 董事兼高级管理人员减持股份计划公告 重要内容提示： ? 董监高持有的基本情况 截至本公告披露日，希荻微电子集团股份有限公司（以下简称"公司"）董 事、副总经理、核心技术人员范俊先生持有公司股份 13,049,225 股，占公司目前 总股本的 3.18%。上述股份均来源于公司首次公开发行前取得的股份，已全部解 除限售。 ? 减持计划的主要内容 公司于 2025 年 8 月 11 日收到范俊先生出具的《关于希荻微电子集团股份有 限公司股份减持计划的告知函》，范俊先生对公司前景持续看好，为满足自身资 金需求，拟通过集中竞价方式减持其持有的公司股份数量合计不超过 3,000,000 股，占公司目前总股本的比例合计不超过 0.73%，减持期间为本公告披露 15 个 交易日后的 3 个月内。减持价格按照市场价格确定，若公司在上述减持计划实施 期间发生派发红利、送红股、转增股本、增 ...

本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 董监高持有的基本情况 截至本公告披露日，希荻微电子集团股份有限公司（以下简称"公司"）董 事、副总经理、核心技术人员范俊先生持有公司股份 13,049,225 股，占公司目前 总股本的 3.18%。上述股份均来源于公司首次公开发行前取得的股份，已全部解 除限售。 证券代码：688173 证券简称：希荻微 公告编号：2025-064 希荻微电子集团股份有限公司 董事兼高级管理人员减持股份计划公告 减持计划的主要内容 公司于 2025 年 8 月 11 日收到范俊先生出具的《关于希荻微电子集团股份有 限公司股份减持计划的告知函》，范俊先生对公司前景持续看好，为满足自身资 金需求，拟通过集中竞价方式减持其持有的公司股份数量合计不超过 3,000,000 股，占公司目前总股本的比例合计不超过 0.73%，减持期间为本公告披露 15 个 交易日后的 3 个月内。减持价格按照市场价格确定，若公司在上述减持计划实施 期间发生派发红利、送红股、转增股本、增发新股或 ...

2024年1至12月份，希荻微的营业收入构成为：集成电路占比99.71%，其他业务占比0.29%。 （文章来源：每日经济新闻） 希荻微（SH 688173，收盘价：15.16元）8月11日晚间发布公告称，截至本公告披露日，希荻微电子集 团股份有限公司董事、副总经理、核心技术人员范俊先生持有公司股份约1305万股，占公司目前总股本 的3.18%。相关股份均来源于公司首次公开发行前取得的股份，已全部解除限售。 公司于2025年8月11日收到范俊先生出具的《关于希荻微电子集团股份有限公司股份减持计划的告知 函》，范俊先生对公司前景持续看好，为满足自身资金需求，拟通过集中竞价方式减持其持有的公司股 份数量合计不超过300万股，占公司目前总股本的比例合计不超过0.73%，减持期间为本公告披露15个 交易日后的3个月内。减持价格按照市场价格确定，若公司在相关减持计划实施期间发生派发红利、送 红股、转增股本、增发新股或配股等股本除权、除息事项的，则相关减持计划将作相应调整。 ...

人民财讯8月11日电，希荻微(688173)8月11日晚间公告，公司董事、副总经理、核心技术人员范俊拟通 过集中竞价方式减持其持有的公司股份数量合计不超过300万股，占公司目前总股本的比例合计不超过 0.73%。 ...

智通财经APP获悉，华安证券发布研报称，德州仪器将在8月启动新一波涨价，幅度超过6月，若特定料 号TI涨价幅度较大，且国产模拟芯片厂商愿意维持价格(不跟进TI涨价)或进一步降价，则在一段时间验 证后的新品量产中也可进行国产替代，TI目前涨价将使得公司保障其现有财务表现但牺牲产品份额。该 行认为国产模拟芯片厂商将有更多机会实现在工业和汽车应用领域，以及高端消费领域的国产替代。 模拟芯片领域相关公司包括：思瑞浦(688536.SH)、杰华特(688141.SH)、圣邦股份(300661.SZ)、纳芯微 (688052.SH)、艾为电子(688798.SH)、希荻微(688173.SH)、必易微(688045.SH)、南芯科技(688484.SH) 等。 华安证券主要观点如下： 德州仪器料号涨价，幅度或将超过6月 根据国际电子商情综合报道，TI将在8月启动新一波涨价，幅度超过6月，重点涉及工控类、车载类、以 及算力相关芯片产品，覆盖LDO(低压差线性稳压器)、DC-DC(直流-直流转换器)、数字隔离、隔离驱动 等品类。而且调价范围不仅涉及终端客户，还覆盖了除超级大客户外的几乎所有客户群体，且价格上调 将通过代理商传 ...

证券代码：688173 证券简称：希荻微 公告编号：2025-063 二、本次限制行权期为 2025 年 8 月 15 日至 2025 年 8 月 29 日，在此期间全 部激励对象将限制行权。 三、公司将按照有关规定及时向中国证券登记结算有限责任公司上海分公司 申请办理限制行权的相关事宜。 特此公告。 提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据《上市公司股权激励管理办法》《希荻微电子集团股份有限公司 2024 年股票期权激励计划（草案）》及中国证券登记结算有限责任公司上海分公司关 于股票期权自主行权的相关规定，结合希荻微电子集团股份有限公司（以下简称 "公司"）2025 年半年度报告的披露计划，现对公司 2024 年股票期权激励计划 的限制行权时间公告如下： | 激励计划 | 行权期 | 行权代码 | | | 实际可行权期限 | | | --- | --- | --- | --- | --- | --- | --- | | 年股票期权激励计 2024 | 第一个行权期 | 1000000597 | 2 ...

Core Viewpoint - The company is actively exploring commercial opportunities for chip products in the AI application sector, particularly in collaboration with partners [1] Group 1: Company Developments - The company has expressed a strong focus on the development trends of AI applications at the edge [1] - High-performance chip products have been sold to domestic tech companies such as Thunderbird through ODM manufacturers [1] - These chips are being applied in end products like AI glasses, although the sales volume and revenue contribution remain relatively small [1]